Benefits of complete coronary revascularization – Counterpoint: what are you talking about? Giuseppe Biondi Zoccai, MD University of Modena and Reggio.

Slides:

Advertisements

Similar presentations

When PCI in NSTEMI? Giuseppe Biondi Zoccai, MD Department of Medico-Surgical Sciences and Biotechnologies Sapienza University of Rome.

Advertisements

After cardiac arrest: emergency coronary angiography for all? Giuseppe Biondi-Zoccai, MD Sapienza University of Rome, Italy

STENT THROMBOSIS: WHICH IMPACT IN REAL CLINICAL PRACTICE? Giuseppe Biondi Zoccai Divisione di Cardiologia, Università di Torino Ospedale S. Giovanni Battista.

Prasugrel vs ticagrelor in acute coronary syndromes

Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy Educational Fellowship in PCI.

Novel antithrombotic agents in acute coronary syndromes: better or worse than P2Y12 inhibitors Giuseppe Biondi Zoccai Sapienza Università di Roma

Pros and cons of FFR in multivessel disease: from FAME to ACS Giuseppe Biondi Zoccai University of Modena and Reggio Emilia, Modena, Italy

FAME 2 year Objective:To investigate the 2-year outcome of PCI guided by FFR in patients with multivessel CAD. Study:Multicenter, single blind, randomized.

New generation devices for the femoro-popliteal district Giuseppe Biondi Zoccai University of Modena and Reggio Emilia

CURRENT PUBLICATION TRENDS IN INTERVENTIONAL CARDIOLOGY Giuseppe Biondi Zoccai Division of Cardiology, University of Turin, Turin, Italy.

Biondi-Zoccai: Peripheral interventions – metcardio.org Basic principles of peripheral interventions Giuseppe Biondi Zoccai University.

8 February 2012, 12:30-13:10 A journey into bioclinical evidence: from bench... to bedside... to population Giuseppe Biondi Zoccai

A Systematic Review On The Hazards Of Aspirin Discontinuation Among Patients With Or At Risk For Coronary Artery Disease Giuseppe Biondi Zoccai Hemodynamics.

Setting up a hybrid suite: truth or myth? Giuseppe Biondi Zoccai, MD University of Modena and Reggio Emilia

Tips and tricks for performing standard meta-regression analysis with SPSS Giuseppe Biondi Zoccai Division of Cardiology, Department of Internal Medicine,

Applications of bivalirudin in interventional cardiology

Title1 Brain Natriuretic Peptide Levels Have A Significant Prognostic Role In Patients With Suspected Or Confirmed Acute Pulmonary Embolism: Evidence From.

PCI vs. CABG: Review of the evidence and suggestions Giuseppe Biondi Zoccai Division of Cardiology, University of Turin, Turin, Italy.

Primer on Statistics for Interventional Cardiologists Giuseppe Sangiorgi, MD Pierfrancesco Agostoni, MD Giuseppe Biondi-Zoccai, MD.

Giuseppe Biondi Zoccai Division of Cardiology University of Turin, Turin Critical aspects of trials on the new generation DES 31st.

Is personalized medicine a hoax? Giuseppe Biondi Zoccai, MD University of Modena and Reggio Emilia

Biondi-Zoccai: CT & coronary angiography – metcardio.org Why coronary CT is inferior to invasive coronary angiography Giuseppe.

Mechanical devices for cardiac massage: must-have or luxury? Mechanical devices for cardiac massage: must-have or luxury? Giuseppe Biondi-Zoccai, MD Sapienza.

Intravascular ultrasound does not provide any significant clinical benefit for percutaneous coronary intervention of bifurcation lesions Giuseppe Biondi.

Multivessel PCI on top of culprit lesion revascularization? No way!

COMPLETE REVASCULARIZATION IN ELDERLY - When it’s contraindicated

Pathophysiology of the coronary circulation: role of FFR Giuseppe Biondi Zoccai University of Modena and Reggio Emilia, Modena, Italy

Gender-related differences in carotid plaque features: focus on instability and inflammation Giuseppe Biondi Zoccai, MD University of Modena and Reggio.

Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy JOINT SYMPOSIUM WITH JACCT - Bologna, 25/9/2008.

Primer on Statistics for Interventional Cardiologists Giuseppe Sangiorgi, MD Pierfrancesco Agostoni, MD Giuseppe Biondi-Zoccai, MD.

Primer on statistical reporting and analyses for continuous variables Giuseppe Biondi Zoccai University of Turin, Turin, Italy

Primer on Statistics for Interventional Cardiologists Giuseppe Sangiorgi, MD Pierfrancesco Agostoni, MD Giuseppe Biondi-Zoccai, MD.

Drug-eluting stent meta-analyses & Long-term follow-up of high-risk subsets: Reconciling the evidence DES e BMS: riflessioni e pensieri 23 febbraio 2007,

Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy BMS & Sanofi Aventis Sponsored.

Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.

Prasugrel in all ACS Patients! Giuseppe Biondi-Zoccai, MD Sapienza University of Rome, Italy

The Benefits of Hiring a Corporate Sedan Service

Giuseppe Biondi Zoccai, M.D.

Clinical need for determination of vulnerable plaques

Primer on Adjusted Indirect Comparison Meta-Analyses

If you really fed-up with your Microsoft Computer then, Call us Toll free and get out of your problems.

If you really fed-up with your Microsoft Computer then, Call us Toll free and get out of your problems.

Giuseppe Biondi Zoccai

A primer on repeat (paired) measure analysis in SPSS

Giuseppe Biondi Zoccai

دانشگاه شهیدرجایی تهران

Diabetes mellitus in patients undergoing percutaneous drug-eluting stent implantation: short and long-term results Claudio Moretti, M.D. Division of Cardiology,

Figure 2 Three-year survival rates on the basis of body composition

Background There is ongoing debate to identify the most effective drug-eluting stent between the two currently most used devices (ie, sirolimus- [SES]

Giuseppe Biondi Zoccai University of Turin, Turin, Italy

تعهدات مشتری در کنوانسیون بیع بین المللی

SMILE Trial design: NSTEMI patients were randomized to complete revascularization during the index procedure (i.e., 1-stage revascularization; n = 264)

Giuseppe Biondi Zoccai, MD

AN INTERNATIONAL COLLABORATIVE META-ANALYSIS ON 1,274 PATIENTS UNDERGOING PERCUTANEOUS DRUG-ELUTING STENTING FOR UNPROTECTED LEFT MAIN CORONARY ARTERY.

Thank You!! For More Information Visit: m/ Call to :

SURGERY EARLY AFTER DES IMPLANTATION

PREDICTORS OF ADVERSE EVENTS IN PATIENTS WITH UNPROTECTED LEFT MAIN DISEASE TREATED WITH DRUG-ELUTING STENTS: EVIDENCE FROM A COLLABORATIVE META-REGRESSION.

CHRONIC TOTAL OCCLUSIONS: WHAT IS KNOWN AND

Role of Stenting in Acute MI: PAMI Stent Pilot Trial

BENEFITS OF CLOPIDOGREL IN PATIENTS UNDERGOING CORONARY STENTING SIGNIFICANTLY DEPEND ON LOADING DOSE: EVIDENCE FROM A SYSTEMATIC REVIEW AND META-REGRESSION.

Single Versus Multiple Vessel Stenting In Patients With St-Elevation Myocardial Infarction: Results From A 30,886-Patient Meta-Analysis Giuseppe Biondi.

Enrollment and Outcomes

ORAL CILOSTAZOL TREATMENT PREVENTS RESTENOSIS AND MAJOR ADVERSE CLINICAL EVENTS AFTER DRUG-ELUTING STENT IMPLANTATION: EVIDENCE FROM A META-ANALYSIS G.

Comparison of radial versus femoral access in patients undergoing invasive management for acute coronary syndromes: evidence from a systematic review and.

Is Prasugrel Superior To Ticagrelor For The Treatment Of Patients With Acute Coronary Syndromes? Evidence From A 32,893-Patient Adjusted Indirect Comparison.

Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.

Effects of Pay-for-Performance on the Quality of Primary Care in England Mean Scores for Clinical Quality at the Practice Level for Aspects of Care for.

Baseline Characteristics of the Patients – Part I

IVUS-XPL Trial design: Patients undergoing drug-eluting stent implantation for long coronary lesions were randomized to IVUS-guided PCI (n = 700) vs. angiography-guided.

Demographic Characteristics of Patients Treated With Statins Versus Those Not Treated With Statins Goldberger JJ, et al. J Am Coll Cardiol 2006;48:

Presentation transcript:

Benefits of complete coronary revascularization – Counterpoint: what are you talking about? Giuseppe Biondi Zoccai, MD University of Modena and Reggio Emilia gbiondizoccai@gmail.com

1. Do you trust angiography? Tonino et al, New Engl J Med 2009

1. Do you trust angiography? Tonino et al, New Engl J Med 2009

2. Have patients really “severe” coronary atherosclerosis? Nam et al, J Am Coll Cardiol 2011

2. Have patients really “severe” coronary atherosclerosis? Nam et al, J Am Coll Cardiol 2011

3. Are MVD patients really so? Tonino et al, J Am Coll Cardiol 2010

3. Are MVD patients really so? Tonino et al, J Am Coll Cardiol 2010

4. Do you trust angioplasty? Boden et al, New Engl J Med 2007

4. Do you trust angioplasty? Boden et al, New Engl J Med 2007

The present is already the past www.cardiacathletes.org/Pioneers

The present is already the past

Thank you for your attention For any correspondence: gbiondizoccai@gmail.com For these and further slides on these topics feel free to visit the metcardio.org website: http://www.metcardio.org/slides.html